Cytotoxic T lymphocyte antigen-4 promoter variants in breast cancer

Cancer Genetics and Cytogenetics

Volumn 165, Issue 2, 2006, Pages 114-120

  Erfani, N ^a   Razmkhah, M ^b   Talei, A R ^a   Pezeshki, A M ^b   Doroudchi, M ^a,b   Monabati, A ^a   Ghaderi, A ^a,b  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; ESTROGEN RECEPTOR;

ADULT; AGED; ARTICLE; BREAST CARCINOGENESIS; BREAST CARCINOMA; CANCER INCIDENCE; CANCER STAGING; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE LOCUS; GENE MUTATION; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HEALTH STATUS; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROMOTER REGION; PROTEIN EXPRESSION; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR IMMUNITY;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION; BREAST NEOPLASMS; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROMOTER REGIONS (GENETICS);

EID: 33644765865     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2005.07.020     Document Type: Article

References (41)

1. J.W. Hadden The immunology and immunotherapy of breast cancer: an update Int J Immunopharmacol 21 1999 79 101
2. V. Di Girolamo, R.P. Laguens, S. Coronato, M. Salas, O. Spinelli, E. Portiansky, and G. Laguens Quantitative and functional study of breast cancer axillary lymph nodes and those draining other human malignant tumors J Exp Clin Cancer Res 19 2000 155 159
3. A.A. Hurwitz, E.D. Kwon, and A. van Elsas Costimulatory wars: the tumor menace Curr Opin Immunol 12 2000 589 596
4. L. Chen Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity Nat Rev Immunol 4 2004 336 347
5. K.M. Lee, E. Chuang, M. Griffin, R. Khattri, D.K. Hong, W. Zhang, D. Straus, L.E. Samelson, C.B. Thompson, and J.A. Bluestone Molecular basis of T cell inactivation by CTLA-4 Science 282 1998 2263 2266
6. J.L. Riley, P.J. Blair, J.T. Musser, R. Abe, K. Tezuka, T. Tsuji, and C.H. June ICOS costimulation requires IL-2 and can be prevented by CTLA-4 engagement J Immunol 166 2001 4943 4948
7. U. Grohmann, C. Orabona, F. Fallarino, C. Vacca, F. Calcinaro, A. Falorni, P. Candeloro, M.L. Belladonna, R. Bianchi, M.C. Fioretti, and P. Puccetti CTLA-4-Ig regulates tryptophan catabolism in vivo Nat Immunol 3 2002 1097 1101
8. + T cells J Exp Med 188 1998 1849 1857
9. M.F. Krummel, and J.P. Allison CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells J Exp Med 183 1996 2533 2540
10. B. Salomon, and J.A. Bluestone Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation Annu Rev Immunol 19 2001 225 252
11. + regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4 J Exp Med 192 2000 303 310
12. T. Kato, and H. Nariuchi Polarization of naive CD4+ T cells toward the Th1 subset by CTLA-4 costimulation J Immunol 164 2000 3554 3562
13. L. Chen, S. Ashe, W.A. Brady, I. Hellstrom, K.E. Hellstrom, J.A. Ledbetter, P. McGowan, and P.S. Linsley Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4 Cell 71 1992 1093 1102
14. D.R. Leach, M.F. Krummel, and J.P. Allison Enhancement of antitumor immunity by CTLA-4 blockade Science 271 1996 1734 1736
15. A. Ribas, J.A. Glaspy, Y. Lee, V.B. Dissette, E. Seja, H.T. Vu, N.S. Tchekmedyian, D. Oseguera, B. Comin-Anduix, J.A. Wargo, S.N. Amarnani, W.H. McBride, J.S. Economou, and L.H. Butterfield Role of dendritic cell phenotype, determinant spreading, and negative costimulatory blockade in dendritic cell-based melanoma immunotherapy J Immunother 27 2004 354 367
16. A.A. Hurwitz, T.F. Yu, D.R. Leach, and J.P. Allison CTLA-4 blockade synergizes with tumor-derived granulocyte-macrophage colony-stimulating factor for treatment of an experimental mammary carcinoma Proc Natl Acad Sci U S A 95 1998 10067 10071
17. V. Ling, P.W. Wu, H.F. Finnerty, M.J. Agostino, J.R. Graham, S. Chen, J.M. Jussiff, G.J. Fisk, C.P. Miller, and M. Collins Assembly and annotation of human chromosome 2q33 sequence containing the CD28, CTLA4, and ICOS gene cluster: analysis by computational, comparative and microarray approaches Genomics 78 2001 155 168
18. L.R. Finger, J. Pu, R. Wasserman, R. Vibhakar, E. Louie, R.R. Hardy, P.D. Burrows, and L.G. Billips The human PD-1 gene: complete cDNA, genomic organization, and developmentally regulated expression in B cell progenitors Gene 197 1997 177 187
19. G.C. Johnson, L. Esposito, B.J. Barratt, A.N. Smith, J. Heward, G. Di Genova, H. Ueda, H.J. Cordell, I.A. Eaves, F. Dudbridge, R.C. Twells, F. Payne, W. Hughes, S. Nutland, H. Stevens, P. Carr, E. Tuomilehto-Wolf, J. Tuomilehto, S.C. Gough, D.G. Clayton, and J.A. Todd Haplotype tagging for the identification of common disease genes Nat Genet 29 2001 233 237
20. K. Deichmann, A. Heinzmann, E. Bruggenolte, J. Forster, and J. Kuehr An Mse I RFLP in the human CTLA4 promotor Biochem Biophys Res Commun 225 1996 817 818
21. H. Donner, H. Rau, P.G. Walfish, J. Braun, T. Siegmund, R. Finke, J. Herwig, K.H. Usadel, and K. Badenhoop CTLA4 alanine-17 confers genetic susceptibility to Graves' disease and to type 1 diabetes mellitus J Clin Endocrinol Metab 82 1997 143 146
22. M.P. Marron, A. Zeidler, L.J. Raffel, S.E. Eckenrode, J.J. Yang, D.I. Hopkins, H.J. Garchon, C.O. Jacob, M. Serrano-Rios, M.T. Martinez Larrad, Y. Park, J.F. Bach, J.I. Rotter, M.C. Yang, and J.X. She Genetic and physical mapping of a type 1 diabetes susceptibility gene (IDDM12) to a 100-kb phagemid artificial chromosome clone containing D2S72-CTLA4-D2S105 on chromosome 2q33 Diabetes 49 2000 492 499
23. M.H. Polymeropoulos, H. Xiao, D.S. Rath, and C.R. Merrill Dinucleotide repeat polymorphism at the human CTLA4 gene Nucleic Acids Res 19 1991 4018
24. O.P. Kristiansen, Z.M. Larsen, and F. Pociot CTLA-4 in autoimmune diseases - a general susceptibility gene to autoimmunity? Genes Immun 1 2000 170 184
25. H. Ueda, J.M. Howson, L. Esposito, J. Heward, H. Snook, G. Chamberlain, D.B. Rainbow, K.M. Hunter, A.N. Smith, G. Di Genova, M.H. Herr, I. Dahlman, F. Payne, D. Smyth, C. Lowe, R.C. Twells, S. Howlett, B. Healy, S. Nutland, H.E. Rance, V. Everett, L.J. Smink, A.C. Lam, H.J. Cordell, N.M. Walker, C. Bordin, J. Hulme, C. Motzo, F. Cucca, J.F. Hess, M.L. Metzker, J. Rogers, S. Gregory, A. Allahabadia, R. Nithiyananthan, E. Tuomilehto-Wolf, J. Tuomilehto, P. Bingley, K.M. Gillespie, D.E. Undlien, K.S. Ronningen, C. Guja, C. Ionescu-Tirgoviste, D.A. Savage, A.P. Maxwell, D.J. Carson, C.C. Patterson, J.A. Franklyn, D.G. Clayton, L.B. Peterson, L.S. Wicker, J.A. Todd, and S.C. Gough Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease Nature 423 2003 506 511
26. M. Monne, G. Piras, A. Palmas, L. Arru, M. Murineddu, G. Latte, A. Noli, and A. Gabbas Cytotoxic T-lymphocyte antigen-4 (CTLA-4) gene polymorphism and susceptibility to non-Hodgkin's lymphoma Am J Hematol 76 2004 14 18
27. C. Zheng, D. Huang, L. Liu, M. Bjorkholm, G. Holm, Q. Yi, and A. Sundblad Cytotoxic T-lymphocyte antigen-4 microsatellite polymorphism is associated with multiple myeloma Br J Haematol 112 2001 216 218
28. A. Ghaderi, F. Yeganeh, T. Kalantari, A.R. Talei, A.M. Pezeshki, M. Doroudchi, and A.S. Dehaghani Cytotoxic T lymphocyte antigen-4 gene in breast cancer Breast Cancer Res Treat 86 2004 1 7
29. A. Ligers, N. Teleshova, T. Masterman, W.X. Huang, and J. Hillert CTLA-4 gene expression is influenced by promoter and exon 1 polymorphisms Genes Immun 2 2001 145 152
30. X.B. Wang, X. Zhao, R. Giscombe, and A.K. Lefvert A CTLA-4 gene polymorphism at position -318 in the promoter region affects the expression of protein Genes Immun 3 2002 233 234
31. S.A. Miller, D.D. Dykes, and H.F. Polesky A simple salting out procedure for extracting DNA from human nucleated cells Nucleic Acids Res 16 1988 1215
32. L. Fernandez-Blanco, E. Perez-Pampin, J.J. Gomez-Reino, and A. Gonzalez A CTLA-4 polymorphism associated with susceptibility to systemic lupus erythematosus Arthritis Rheum 50 2004 328 329
33. L.L. Hudson, K. Rocca, Y.W. Song, and J.P. Pandey CTLA-4 gene polymorphisms in systemic lupus erythematosus: a highly significant association with a determinant in the promoter region Hum Genet 111 2002 452 455
34. H. Hadj Kacem, M. Bellassoued, N. Bougacha-Elleuch, M. Abid, and H. Ayadi CTLA-4 gene polymorphisms in Tunisian patients with Graves' disease Clin Immunol 101 2001 361 365
35. R.K. Saiki, T.L. Bugawan, G.T. Horn, K.B. Mullis, and H.A. Erlich Analysis of enzymatically amplified beta-globin and HLA-DQ alpha DNA with allele-specific oligonucleotide probes Nature 324 1986 163 166
36. J. Braun, H. Donner, T. Siegmund, P.G. Walfish, K.H. Usadel, and K. Badenhoop CTLA-4 promoter variants in patients with Graves' disease and Hashimoto's thyroiditis Tissue Antigens 51 1998 563 566
37. T. Kalantari, H. Mostafavi, A.M. Pezeshki, S. Farjadian, M. Doroudchi, F. Yeganeh, and A. Ghaderi Exon-1 polymorphism of CTLA4 gene in Iranian patients with Graves' disease Autoimmunity 36 2003 313 316
38. Z. Mojtahedi, R. Omrani, M. Doroudchi, and A. Ghaderi CTLA-y +49 A/6 polymorphism is associated with predisposition to type 1 diabetes in Iranians Diabetes Res Clin Pract 68 2 2005 111 116
39. A. Ide, E. Kawasaki, N. Abiru, F. Sun, M. Kobayashi, T. Fukushima, R. Takahashi, H. Kuwahara, A. Kita, K. Oshima, S. Uotani, H. Yamasaki, Y. Yamaguchi, and K. Eguchi Association between IL-18 gene promoter polymorphisms and CTLA-4 gene 49A/G polymorphism in Japanese patients with type 1 diabetes J Autoimmun 22 2004 73 78
40. T. Yanagawa, K. Gomi, E.I. Nakao, and S. Inada CTLA-4 gene polymorphism in Japanese patients with rheumatoid arthritis J Rheumatol 27 2000 2740 2742
41. A.L. Mellor, P. Chandler, B. Baban, A.M. Hansen, B. Marshall, J. Pihkala, H. Waldmann, S. Cobbold, E. Adams, and D.H. Munn Specific subsets of murine dendritic cells acquire potent T cell regulatory functions following CTLA4-mediated induction of indoleamine 2,3 dioxygenase Int Immunol 16 2004 1391 1401